- Home
- GANX vs NRT Comparison
GANX vs NRT Comparison
Compare GANX & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GANX | NRT |
|---|---|---|
| Founded | 2017 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.2M | 76.7M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GANX | NRT |
|---|---|---|
| Price | $2.00 | $7.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 560.0K | 51.6K |
| Earning Date | 05-13-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 10.18% |
| EPS Growth | ★ 31.46 | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $55,180.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $38.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.41 | $4.76 |
| 52 Week High | $4.34 | $10.49 |
Technical Indicators
Market Signals| Indicator | GANX | NRT |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 45.56 |
| Support Level | $1.65 | $7.90 |
| Resistance Level | $2.11 | $9.52 |
| Average True Range (ATR) | 0.13 | 0.30 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 83.65 | 29.95 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.